JQEZ5
Chemical Name: N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxamide
Purity: ≥98%
Biological Activity
JQEZ5 is a potent and selective SAM-competitive EZH2 lysine methyltransferase inhibitor (IC50 = 11 nM). Selectively binds EZH2 over a panel of 22 methyltransferases. Reduces global level of the PRC2-associated mark H3K27me3 in K562 cells. Suppresses cell growth in CML cells. Inhibits colony formation of primary human CD34+ CML stem/ progenitor cells. Antitumor effects in vivo.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
Chronic myelogenous leukemia- initiating cells require polycomb group protein EZH2.
Xie et al.
Send to, 2016;6:1237 -
Developing EZH2-targeted therapy for lung cancer.
Frankel et al.
Cancer Discov., 2016;6:949 -
Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer.
Zhang et al.
Cancer Discov., 2016;6:1006
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for JQEZ5
There are currently no reviews for this product. Be the first to review JQEZ5 and earn rewards!
Have you used JQEZ5?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
